Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsORALGeneric

GALANTAMINE HYDROBROMIDE

GALANTAMINE HYDROBROMIDE

Standard Dose
8MG
Max Dose
Refer to approved labeling
Primary Use
Marketing status: None (Tentative Approval)
Summary

Approval overview GALANTAMINE HYDROBROMIDE is listed in Drugs@FDA under application 077592 (ANDA).

Marketing status: None (Tentative Approval) Active ingredient GALANTAMINE HYDROBROMIDE Form and strength TABLET; ORAL - 8MG Sponsor SUN PHARM INDS Submission history Latest submission status date: 2007-08-28 00:00:00.

Structured Monograph

Clinical summary

Approval overview GALANTAMINE HYDROBROMIDE is listed in Drugs@FDA under application 077592 (ANDA). Marketing status: None (Tentative Approval) Active ingredient GALANTAMINE HYDROBROMIDE Form and strength TABLET; ORAL - 8MG Sponsor SUN PHARM INDS Submission history Latest submission status date: 2007-08-28 00:00:00. Submission type: ORIG.

Monitoring

  • • Marketing status: None (Tentative Approval)

Interaction Notes

  • No interaction notes stored yet.